Protective effects of recombinant human erythropoietin against pressure overload-induced left ventricular remodeling and premature death in mice.

The Tohoku journal of experimental medicine

Volumn 225, Issue 2, 2011, Pages 131-143

  Wang, Wanting ^a   Kagaya, Yutaka ^b   Asaumi, Yasuhide ^b   Fukui, Shigefumi ^b   Takeda, Morihiko ^b   Shimokawa, Hiroaki ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPO PROTEIN, HUMAN; ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD PRESSURE; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART MUSCLE CELL; HEART VENTRICLE; HEART VENTRICLE REMODELING; HEMODYNAMICS; LONGEVITY; MALE; METABOLISM; MOUSE; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PREMATURE MORTALITY; SURVIVAL RATE;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ERYTHROPOIETIN; HEART VENTRICLES; HEMODYNAMICS; LONGEVITY; MALE; MICE; MICE, INBRED C57BL; MORTALITY, PREMATURE; MYOCYTES, CARDIAC; ORGAN SIZE; RECOMBINANT PROTEINS; SURVIVAL RATE; VENTRICULAR REMODELING;

EID: 84855375368     PISSN: None     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.225.131     Document Type: Article

References (0)